2-MPMDQα1-adrenoceptor antagonist,potent and selective CAS# 149847-77-8 |
2D Structure
- ABT-751 (E7010)
Catalog No.:BCC1085
CAS No.:141430-65-1
- CHM 1
Catalog No.:BCC2387
CAS No.:154554-41-3
- Podophyllotoxin
Catalog No.:BCN5957
CAS No.:518-28-5
- D-64131
Catalog No.:BCC1510
CAS No.:74588-78-6
- CYT997 (Lexibulin)
Catalog No.:BCC4601
CAS No.:917111-44-5
- MPC 6827 hydrochloride
Catalog No.:BCC8040
CAS No.:917369-31-4
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 149847-77-8 | SDF | Download SDF |
PubChem ID | 4534085 | Appearance | Powder |
Formula | C23H27N5O2 | M.Wt | 405.5 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble to 50 mM in DMSO | ||
Chemical Name | 2-[[4-(2-methoxyphenyl)piperazin-1-yl]methyl]-6-methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5-one | ||
SMILES | CN1C2=CC=CC=C2C3=NC(CN3C1=O)CN4CCN(CC4)C5=CC=CC=C5OC | ||
Standard InChIKey | OULFYKAESNCMFJ-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C23H27N5O2/c1-25-19-8-4-3-7-18(19)22-24-17(16-28(22)23(25)29)15-26-11-13-27(14-12-26)20-9-5-6-10-21(20)30-2/h3-10,17H,11-16H2,1-2H3 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Potent and selective α1-adrenoceptor antagonist; hypotensive. |
2-MPMDQ Dilution Calculator
2-MPMDQ Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.4661 mL | 12.3305 mL | 24.6609 mL | 49.3218 mL | 61.6523 mL |
5 mM | 0.4932 mL | 2.4661 mL | 4.9322 mL | 9.8644 mL | 12.3305 mL |
10 mM | 0.2466 mL | 1.233 mL | 2.4661 mL | 4.9322 mL | 6.1652 mL |
50 mM | 0.0493 mL | 0.2466 mL | 0.4932 mL | 0.9864 mL | 1.233 mL |
100 mM | 0.0247 mL | 0.1233 mL | 0.2466 mL | 0.4932 mL | 0.6165 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
2-MPMDQ is a potent and selective antagonist of α1-adrenoceptor [1].
α1-adrenoceptor is a G protein-coupled receptor and mediates noradrenaline and adrenaline signal in the central and peripheral nervous systems. Also, α1-adrenoceptor mediates smooth muscle contraction.
2-MPMDQ is a potent and selective α1-adrenoceptor antagonist. In spontaneously hypertensive rats, 2-MPMDQ showed antihypertensive activity [1].
Reference:
[1]. Chern JW, Tao PL, Yen MH, et al. Studies on quinazolines. 5. 2,3-dihydroimidazo[1,2-c]quinazoline derivatives: a novel class of potent and selective alpha 1-adrenoceptor antagonists and antihypertensive agents. J Med Chem, 1993, 36(15): 2196-2207.
- Saquinavir mesylate
Catalog No.:BCC1922
CAS No.:149845-06-7
- Homoeriodictyol 7-O-glucoside
Catalog No.:BCN7740
CAS No.:14982-11-7
- Delaminomycin A
Catalog No.:BCN1833
CAS No.:149779-38-4
- Clemastine Fumarate
Catalog No.:BCC4528
CAS No.:14976-57-9
- Tereticornate A
Catalog No.:BCN1667
CAS No.:149751-81-5
- H-Arg-NH2.2HCl
Catalog No.:BCC2859
CAS No.:14975-30-5
- RS 23597-190 hydrochloride
Catalog No.:BCC6767
CAS No.:149719-06-2
- AHU-377(Sacubitril)
Catalog No.:BCC4088
CAS No.:149709-62-6
- Stachybotrolide
Catalog No.:BCN6968
CAS No.:149691-31-6
- Pefloxacin Mesylate Dihydrate
Catalog No.:BCC5089
CAS No.:149676-40-4
- Isomorellinol
Catalog No.:BCN3075
CAS No.:149655-53-8
- Isogambogic acid
Catalog No.:BCN3078
CAS No.:149655-52-7
- AAL Toxin TB1
Catalog No.:BCN1734
CAS No.:149849-90-1
- AAL Toxin TB2
Catalog No.:BCN1739
CAS No.:149849-91-2
- Azimilide Dihydrochloride
Catalog No.:BCC5536
CAS No.:149888-94-8
- H-Glu(OMe)-OH
Catalog No.:BCC2931
CAS No.:1499-55-4
- Azimilide
Catalog No.:BCC5535
CAS No.:149908-53-2
- 9-Aminominocycline hydrochloride
Catalog No.:BCC8797
CAS No.:149934-21-4
- Z-His-OH
Catalog No.:BCC2768
CAS No.:14997-58-1
- 5-O-Methyldalbergiphenol
Catalog No.:BCN8104
CAS No.:1499946-35-8
- Gelomuloside A
Catalog No.:BCN6639
CAS No.:149998-38-9
- Gelomuloside B
Catalog No.:BCN6640
CAS No.:149998-39-0
- O-Acetylschisantherin L
Catalog No.:BCN3635
CAS No.:149998-51-6
- m-Methoxyphenol
Catalog No.:BCN1669
CAS No.:150-19-6
Studies on quinazolines. 5. 2,3-dihydroimidazo[1,2-c]quinazoline derivatives: a novel class of potent and selective alpha 1-adrenoceptor antagonists and antihypertensive agents.[Pubmed:8101878]
J Med Chem. 1993 Jul 23;36(15):2196-207.
A series of 2-[(substituted phenylpiperazin-1-yl)methyl]- and 2-[(substituted phenylpiperidin-1-yl)methyl]-2,3-dihydroimidazo[1,2- c]quinazolin-5(6H)-ones or -5(6H)-thiones, and 3-[(substituted phenylpiperazin-1-yl)methyl]-2,3-dihydroimidazo[1,2-c]quinaz oline derivatives were synthesized, as conformationally restricted analogues of SGB-1534 and ketanserin, for evaluation as alpha-antagonists and antihypertensive agents. Most compounds containing a (substituted phenylipiperazinyl)methyl side chain displayed high binding affinity for alpha 1-adrenoceptor with no significant activity at alpha 2-sites. Compounds having a (substituted phenylpiperazinyl)methyl at the 3-position of 2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one ring system had a better activity than those with the same substituent at the 2-position. Structure-activity relationships for alpha 1-adrenoceptor affinity are presented and indicate that compounds with substitution at the ortho position on the benzene ring of the phenylpiperazine side chain moiety are more potent than those without substitution and/or substitutions at the 3- and 4-positions. Computer-assisted superimposition of SGB-1534 and 20b showed little structural correspondence between the quinazolinone and 2,3-dihydroimidazo[1,2-c]quinazoline nucleus, and specific interactions of these molecular fragments with the receptor protein appear unlikely. Antihypertensive activity was evaluated via intravenous administration of each compound to spontaneously hypertensive rats, and compounds (16a, 16b, 20b, and 28b) illustrated similar efficacy to SGB-1534 when assessed after 6 h. The pA2 value for 16a against phenylephedrine in rat aorta was much higher than that of prazosin. On the basis of alpha 1-adrenoceptor affinity/selectivity in vitro and duration of antihypertensive action in vivo, compounds 20b and 28b warrant further evaluation.